Geode Capital Management, LLC Nrx Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.29 - $0.7 $2,329 - $5,622	8,032 Added 1.95%	419,954 $197,000
Q3 2023 Nov 13, 2023	BUY	$0.23 - $0.5 $7,648 - $16,627	33,255 Added 8.78%	411,922 $107,000
Q4 2022 Feb 13, 2023	BUY	$0.79 - $9.19 $45,851 - $533,387	58,040 Added 18.1%	378,667 $420,000
Q3 2022 Nov 14, 2022	BUY	$0.2 - $8.07 $2,439 - $98,413	12,195 Added 3.95%	320,627 $237,000
Q2 2022 Aug 12, 2022	BUY	$0.51 - $2.42 $7,428 - $35,247	14,565 Added 4.96%	308,432 $185,000
Q1 2022 May 13, 2022	BUY	$2.45 - $5.04 $201,799 - $415,129	82,367 Added 38.94%	293,867 $719,000
Q4 2021 Feb 11, 2022	BUY	$4.5 - $11.91 $745,803 - $1.97 Million	165,734 Added 362.13%	211,500 $1.01 Million
Q3 2021 Nov 12, 2021	BUY	$8.52 - $24.77 $96,199 - $279,678	11,291 Added 32.75%	45,766 $424,000
Q2 2021 Aug 13, 2021	BUY	$11.62 - $44.5 $400,599 - $1.53 Million	34,475 New	34,475 $400,000

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $101M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.